toosendanin has been researched along with Neuroblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Shi, YL; Xu, TH | 1 |
| Li, MF; Shi, YL; Wang, ZF; Wu, Y | 1 |
| Hu, Q; Huang, F; Shi, Y | 1 |
3 other study(ies) available for toosendanin and Neuroblastoma
| Article | Year |
|---|---|
Toosendanin increases free-Ca(2+) concentration in NG108-15 cells via L-type Ca(2+) channels.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Differentiation; Drugs, Chinese Herbal; Glioma; Hybrid Cells; Neuroblastoma; Nifedipine; Tumor Cells, Cultured | 2004 |
Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Membrane Potentials; Mice; Neuroblastoma; Patch-Clamp Techniques | 2004 |
Inhibition of Toosendanin on the delayed rectifier potassium current in neuroblastoma x glioma NG108-15 cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Delayed Rectifier Potassium Channels; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glioma; Hybrid Cells; Mice; Neuroblastoma; Neuromuscular Blocking Agents; Nifedipine; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Tetraethylammonium; Tetraethylammonium Compounds; Verapamil | 1997 |